Class 4 Medicines Defect Information: Max Healthcare Paracetamol 500 mg Capsules (Max Remedies Ltd)
Class 4 Medicines Defect Information: Max Healthcare Paracetamol 500 mg Capsules (Max Remedies Ltd)
Drug alert number:EL (23)A/37
Date issued: 27 September 2023
The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Max Healthcare Paracetamol 500 mg Capsules (Max Remedies Ltd)
Company name: Max Remedies Ltd
Product name: Max Healthcare Paracetamol 500 mg Capsules PL 31308/0004
Batch No | Expiry Date | Pack Size | First Distributed |
EG22PAA040 | Nov 2025 | 16 Capsule Pack | March 2023 |
EG22PAA041 | Nov 2025 | 16 Capsule Pack | March 2023 |
EG23PAA001 | Dec 2025 | 16 Capsule Pack | May 2023 |
EG23PAA002 | Dec 2025 | 16 Capsule Pack | May 2023 |
EG23PAA003 | Dec 2025 | 16 Capsule Pack | May 2023 |
EG23PAA004 | Dec 2025 | 16 Capsule Pack | May 2023 |
EG23PAA005 | Dec 2025 | 16 Capsule Pack | May 2023 |
EG23PAA006 | Dec 2025 | 16 Capsule Pack | May 2023 |
EG23PAA010 | Feb 2026 | 16 Capsule Pack | June 2023 |
EG23PAA011 | Feb 2026 | 16 Capsule Pack | June 2023 |
EG23PAA012 | Feb 2026 | 16 Capsule Pack | June 2023 |
EG23PAA013 | Feb 2026 | 16 Capsule Pack | June 2023 |
EG23PAA014 | Feb 2026 | 16 Capsule Pack | June 2023 |
EG23PAA015 | Feb 2026 | 16 Capsule Pack | July 2023 |
EG23PAA016 | April 2026 | 16 Capsule Pack | July 2023 |
EG23PAA017 | April 2026 | 16 Capsule Pack | July 2023 |
EG23PAA018 | April 2026 | 16 Capsule Pack | July 2023 |
EG23PAA019 | April 2026 | 16 Capsule Pack | July 2023 |
EG23PAA020 | April 2026 | 16 Capsule Pack | July 2023 |
EG23PAA021 | April 2026 | 16 Capsule Pack | July 2023 |
Active Pharmaceutical Ingredient: Paracetamol
Brief description of the problem
Max Remedies has identified an infrequent printing error relating to the Braille text printed on the cartons. Some characters may be incorrect leading to potential misinterpretation of the contents/strength of the product.
Specific examples of the types of error reported include:
Observed Incomplete Braille | Potential Misinterpretation |
T from PARACETAMOL | Read as “PARACEJAMOL” |
L from CAPSULES | No equivalent character |
U from CAPSULES | Read as “:” or “-“ |
P from PARACETAMOL | Read as “FARACETAMOL” |
0 from 500 | Read as “50:” |
0 from 500 | Read as “50-“ |
U from CAPSULES | Read as “:” or ”–“ |
M from mg | No equivalent character |
M from mg | Read as “fg” |
P from CAPSULES | Read as “CAFSULES” |
P from CAPSULES | Read as “CA/SULES” |
Advice for healthcare professionals and retailers
We would advise that blind and/or partially sighted patients are instructed to follow the directions outlined in the PIL as normal and if there are concerns, they should consult with their carer, or alternatively contact Max Remedies. The quality of the capsules is not impacted by this defect and all written information on the packs is correct.
View full alert here.
Further Information
For medical information enquiries or stock control enquiries please email Gary.Elliott@ivcbrunel.co.uk or telephone 07720740832